Multiple Sclerosis disease distribution and potential impact of environmental air pollutants in Georgia

Science of the Total Environment

Volumn 396, Issue 1, 2008, Pages 42-51

  Gregory II, Anthony Charles ^a,b   Shendell, Derek G ^a,c   Okosun, Ike S ^a   Gieseker, Karen E ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

Environment; Epidemiology; Multiple Sclerosis; Particulate matter; Toxicants

Indexed keywords

AIR POLLUTION; GEOGRAPHIC INFORMATION SYSTEMS; LAWS AND LEGISLATION; NEUROLOGY; REGRESSION ANALYSIS; TOXIC MATERIALS;

ENVIRONMENTAL FACTORS; METROPOLITAN STATISTICAL AREA (MSA); MULTIPLE SCLEROSIS; PER CAPITA INCOME;

DISEASES;

AIR QUALITY; ATMOSPHERIC POLLUTION; DISEASE PREVALENCE; EPIDEMIOLOGY; GIS; HEALTH IMPACT; HEALTH RISK; IMMUNE RESPONSE; METROPOLITAN AREA; NERVOUS SYSTEM DISORDER; PARTICULATE MATTER; POLLUTION EXPOSURE; REGRESSION ANALYSIS; TOXIC SUBSTANCE;

AIR POLLUTANT; AIR POLLUTION; ARTICLE; CONTROLLED STUDY; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; POLLUTION; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; UNITED STATES;

AIR POLLUTANTS; CROSS-SECTIONAL STUDIES; ENVIRONMENTAL EXPOSURE; FEMALE; GEORGIA; HUMANS; MALE; MULTIPLE SCLEROSIS; QUESTIONNAIRES;

GEORGIA; NORTH AMERICA; UNITED STATES;

EID: 42749089604     PISSN: 00489697     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2008.01.065     Document Type: Article

References (52)

1. Anderson D.W., Ellenberg J.H., Leventhal C.M., Reingold S.C., Rodriguez M., and Silberberg D.H. Revised estimate of the prevalence of multiple sclerosis in the United States. Ann Neurol 31 3 (1992) 333-336
2. Baum H.M., and Rothschild B.B. The incidence and prevalence of reported multiple sclerosis. Ann Neurol 10 5 (1981) 420-428
3. Berti R., Brennan M.B., Soldan S.S., Ohayon J.M., Casareto L., McFarland H.F., et al. Increased detection of serum HHV-6 DNA sequences during multiple sclerosis (MS) exacerbations and correlation with parameters of MS disease progression. J Neurovirol 8 3 (2002) 250-256
4. Berti R., Soldan S.S., Akhyani N., McFarland H.F., and Jacobson S. Extended observations on the association of HHV-6 and Multiple Sclerosis. J Neurovirol 6 Suppl 2 (2000) S85-S87
5. Bolviken B., Celius E.G., Nilsen R., and Strand T. Radon: a possible risk factor in multiple sclerosis. Neuroepidemiology 22 1 (2003) 87-94
6. Bom K. Particle toxicology (2007), CRC Press, Boca Raton, FL
7. Cantorna M.T., Hayes C.E., and DeLuca H.F. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci U S A 93 15 (1996) 7861-7864
8. Cantorna M.T., Woodward W.D., Hayes C.E., and DeLuca H.F. 1,25-Dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta 1 and IL-4. J Immunol 160 11 (1998) 5314-5319
9. Catanzaro M., and Weinert C. Economic status of families living with multiple sclerosis. Int J Rehabil Res 15 3 (1992) 209-218
10. Cepok S., Zhou D., Srivastava R., Nessler S., Stei S., Bussow K., et al. Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J Clin Invest 115 5 (2005) 1352-1360
11. Corel-Corporation. 2000. Corel Draw 10.
12. Dal Canto M.C., Melvold R.W., Kim B.S., and Miller S.D. Two models of multiple sclerosis: experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection. A pathological and immunological comparison. Microsc Res Tech 32 3 (1995) 215-229
13. de la Maza M., Garcia J., Bernal J., and Fuentes M. [A review of the epidemiology of multiple sclerosis in Mexico]. Rev Neurol 31 5 (2000) 494-495
14. de Rezende P.A., and Arruda W.O. [Genetic aspects in multiple sclerosis: I. Twin studies]. Arq Neuropsiquiatr 54 3 (1996) 433-438
15. Dyment D.A., Ebers G.C., and Sadovnick A.D. Genetics of multiple sclerosis. Lancet Neurol 3 2 (2004) 104-110
16. Ebers G.C., Kukay K., Bulman D.E., Sadovnick A.D., Rice G., Anderson C., et al. A full genome search in multiple sclerosis. Nat Genet 13 4 (1996) 472-476
17. Edwards S., Zvartau M., Clarke H., Irving W., and Blumhardt L.D. Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis. J Neurol Neurosurg Psychiatry 64 6 (1998) 736-741
18. Fazekas F., Barkhof F., Filippi M., Grossman R.I., Li D.K., McDonald W.I., et al. The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis. Neurology 53 3 (1999) 448-456
19. Freedman D.M., Dosemeci M., and Alavanja M.C. Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates. Occup Environ Med 57 6 (2000) 418-421
20. Gregory A. 2007. Multiple Sclerosis disease distribution and potential impact of environmental air pollutants in Georgia Atlanta: Georgia State University. MPH Thesis. Available on campus library system at http://etd.gsu.edu/theses/available/etd-07132007-171733/.
21. Haahr S., Plesner A.M., Vestergaard B.F., and Hollsberg P. A role of late Epstein-Barr virus infection in multiple sclerosis. Acta Neurol Scand 109 4 (2004) 270-275
22. Hansen T., Skytthe A., Stenager E., Petersen H.C., Kyvik K.O., and Bronnum-Hansen H. Risk for multiple sclerosis in dizygotic and monozygotic twins. Mult Scler 11 5 (2005) 500-503
23. Henry J., Williamson D.M., Schiffer R., Wagner L., Shire J., and Garabedian M. Investigation of a cluster of multiple sclerosis in two elementary school cohorts. J Environ Health 69 10 (2007) 34-38
24. Hogancamp W.E., Rodriguez M., and Weinshenker B.G. The epidemiology of multiple sclerosis. Mayo Clin Proc 72 9 (1997) 871-878
25. Ingalls T.H. Endemic clustering of multiple sclerosis in time and place, 1934-1984. Confirmation of a hypothesis. Am J Forensic Med Pathol 7 1 (1986) 3-8
26. Ito H., Yamasaki K., Kawano Y., Horiuchi I., Yun C., Nishimura Y., et al. HLA-DP-associated susceptibility to the optico-spinal form of multiple sclerosis in the Japanese. Tissue Antigens 52 2 (1998) 179-182
27. Keegan B.M., and Noseworthy J.H. Multiple sclerosis. Annu Rev Med 53 (2002) 285-302
28. Kong H., Baerbig Q., Duncan L., Shepel N., and Mayne M. Human herpesvirus type 6 indirectly enhances oligodendrocyte cell death. J Neurovirol 9 5 (2003) 539-550
29. Kurtzke J.F. Multiple sclerosis in time and space-geographic clues to cause. J Neurovirol 6 Suppl 2 (2000) S134-S140
30. Landrigan P.J., Gehlbach S.H., Rosenblum B.F., Shoults J.M., Candelaria R.M., Barthel W.F., et al. Epidemic lead absorption near an ore smelter. The role of particulate lead. N Engl J Med 292 3 (1975) 123-129
31. Lunemann J.D., Edwards N., Muraro P.A., Hayashi S., Cohen J.I., Munz C., et al. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis. Brain 129 Pt 6 (2006) 1493-1506
32. Mayer J. Geographical clues about multiple sclerosis. Ann Assoc Am Geogr 71 1 (1981) 28
33. Microsoft-Corporation. 2004. Microsoft Excel 2004 for Mac.
34. Munger K.L., Zhang S.M., O'Reilly E., Hernan M.A., Olek M.J., Willett W.C., et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 62 1 (2004) 60-65
35. Ogawa G., Mochizuki H., Kanzaki M., Kaida K., Motoyoshi K., and Kamakura K. Seasonal variation of multiple sclerosis exacerbations in Japan. Neurol Sci 24 6 (2004) 417-419
36. Oikonen M., Laaksonen M., Laippala P., Oksaranta O., Lilius E.M., Lindgren S., et al. Ambient air quality and occurrence of multiple sclerosis relapse. Neuroepidemiology 22 1 (2003) 95-99
37. Oksenberg J.R., Baranzini S.E., Barcellos L.F., and Hauser S.L. Multiple sclerosis: genomic rewards. J Neuroimmunol 113 2 (2001) 171-184
38. Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurol Sci 22 2 (2001) 117-139
39. Soldan S.S., Berti R., Salem N., Secchiero P., Flamand L., Calabresi P.A., et al. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat Med 3 12 (1997) 1394-1397
40. Sospedra M., and Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 23 (2005) 683-747
41. Sospedra M., Zhao Y., zur Hausen H., Muraro P.A., Hamashin C., de Villiers E.M., et al. Recognition of conserved amino acid motifs of common viruses and its role in autoimmunity. PLoS Pathog 1 4 (2005) e41
42. Spach K.M., and Hayes C.E. Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice. J Immunol 175 6 (2005) 4119-4126
43. SPSS. 2005. SPSS for Windows.
44. Sumaya C.V., Myers L.W., Ellison G.W., and Ench Y. Increased prevalence and titer of Epstein-Barr virus antibodies in patients with multiple sclerosis. Ann Neurol 17 4 (1985) 371-377
45. Tejada-Simon M.V., Zang Y.C., Hong J., Rivera V.M., and Zhang J.Z. Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis. Ann Neurol 53 2 (2003) 189-197
46. Thompson A.J., Polman C.H., Miller D.H., McDonald W.I., Brochet B., Filippi M.M.X., et al. Primary progressive multiple sclerosis. Brain 120 Pt 6 (1997) 1085-1096
47. Tuke P.W., Hawke S., Griffiths P.D., and Clark D.A. Distribution and quantification of human herpesvirus 6 in multiple sclerosis and control brains. Mult Scler 10 4 (2004) 355-359
48. Virtanen J.O., Zabriskie J.B., Siren V., Friedman J.E., Lyons M.J., Edgar M., et al. Co-localization of human herpes virus 6 and tissue plasminogen activator in multiple sclerosis brain tissue. Med Sci Monit 11d 3 (2005) BR84-BR87
49. Wandinger K., Jabs W., Siekhaus A., Bubel S., Trillenberg P., Wagner H., et al. Association between clinical disease activity and Epstein-Barr virus reactivation in MS. Neurology 55 2 (2000) 178-184
50. Weinshenker B.G. The natural history of multiple sclerosis: update 1998. Semin Neurol 18 3 (1998) 301-307
51. Williamson D.M., and Henry J.P. Challenges in addressing community concerns regarding clusters of multiple sclerosis and potential environmental exposures. Neuroepidemiology 23 5 (2004) 211-216
52. Williamson D.M., Henry J.P., Schiffer R., and Wagner L. Prevalence of multiple sclerosis in 19 Texas counties, 1998-2000. J Environ Health 69 10 (2007) 41-45